Effect of synthetic antioxidants on the oxidative stability of biodiesel

Biodiesels were prepared using base catalyzed methanolysis of sunflower, soybean and canola oils. Rancimat oxidative stability measurements showed that the induction period (IP) for neat canola biodiesel conformed to EN 14214, the European specification for biodiesel (IP > 6 h). Stability was enhanced when 0.5 wt.% of the synthetic antioxidants di-tert-butylhydroquinone (DTBHQ) or poly(1,2-dihydro- 2,2,4-trimethylquinoline) (Orox PK) was added. Soybean-based biodiesel spiked with 0.5 wt.% DTBHQ also reached this specification. Orox PK improved the stability of sunflower biodiesel but the 3 h induction period specified by ASTM D-6751 could not be reached. Curiously, canola biodiesel was destabilized on adding the antioxidant Naugard P (tris(nonylphenyl) phosphite).The Institutional Research Development Programme (IRDP) and the THRIP program of the Department of Trade and Industry and the National Research Foundation of South Africa, Ltd as well as Xyris Technology.http://www.elsevier.com/locate/fuelai201

Implicit Stochastic Optimization for deriving reservoir operating rules in semiarid Brazil

Este artigo investiga a aplicação de Otimização Estocástica Implícita (OEI) para determinar regras de operações mensais em um sistema de reservatórios localizado no nordeste semi-árido brasileiro. OEI emprega um modelo de otimização determinística para encontrar alocações ótimas do reservatório sob vários cenários possíveis de afluências e posteriormente constrói as regras a partir da análise deste conjunto de liberações ótimas. As políticas operacionais fornecem a alocação mensal do reservatório condicionada ao armazenamento no início do mês e a afluência prevista para o mês. Além da clássica análise de regressão, este estudo estabelece as regras por meio de uma estratégia de interpolação bidimensional. Após a sua identificação, as regras são aplicadas para operar o sistema sob novas realizações de afluências e mostram habilidade para produzir políticas semelhantes às obtidas a partir de otimização determinística tendo estas mesmas afluências como previsão perfeita.._________________________________________________________________________________________ ABSTRACT: This paper deals with the application of Implicit Stochastic Optimization (ISO) to determine monthly operating rules for a reservoir system located in the semiarid Northeast of Brazil. ISO employs a deterministic optimization model to find optimal reservoir allocations under several possible inflow scenarios and later constructs the rules by analyzing the ensemble of these optimal releases. The operating policies provide the monthly reservoir release conditioned on the storage at the beginning of the month and the inflow predicted for the month. In addition to the classical regression analysis, this study establishes the rules by a two-dimensional interpolation strategy. After the rules are identified, they are applied to operate the system under new inflow realizations and show ability to produce policies similar to those obtained by deterministic optimization taking the same inflows as perfect forecasts

Soluble forms of tau are toxic in Alzheimer's disease

Accumulation of neurofibrillary tangles (NFT), intracellular inclusions of fibrillar forms of tau, is a hallmark of Alzheimer Disease. NFT have been considered causative of neuronal death, however, recent evidence challenges this idea. Other species of tau, such as soluble misfolded, hyperphosphorylated, and mislocalized forms, are now being implicated as toxic. Here we review the data supporting soluble tau as toxic to neurons and synapses in the brain and the implications of these data for development of therapeutic strategies for Alzheimer’s disease and other tauopathies

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

A proportion of patients infected with severe acute respiratory syndrome coronavirus 2 experience a range of neuropsychiatric symptoms months after infection, including cognitive deficits, depression and anxiety. The mechanisms underpinning such symptoms remain elusive. Recent research has demonstrated that nervous system injury can occur during COVID-19. Whether ongoing neural injury in the months after COVID-19 accounts for the ongoing or emergent neuropsychiatric symptoms is unclear. Within a large prospective cohort study of adult survivors who were hospitalized for severe acute respiratory syndrome coronavirus 2 infection, we analysed plasma markers of nervous system injury and astrocytic activation, measured 6 months post-infection: neurofilament light, glial fibrillary acidic protein and total tau protein. We assessed whether these markers were associated with the severity of the acute COVID-19 illness and with post-acute neuropsychiatric symptoms (as measured by the Patient Health Questionnaire for depression, the General Anxiety Disorder assessment for anxiety, the Montreal Cognitive Assessment for objective cognitive deficit and the cognitive items of the Patient Symptom Questionnaire for subjective cognitive deficit) at 6 months and 1 year post-hospital discharge from COVID-19. No robust associations were found between markers of nervous system injury and severity of acute COVID-19 (except for an association of small effect size between duration of admission and neurofilament light) nor with post-acute neuropsychiatric symptoms. These results suggest that ongoing neuropsychiatric symptoms are not due to ongoing neural injury

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Background: Sleep disturbance is common following hospital admission both for COVID-19 and other causes. The clinical associations of this for recovery after hospital admission are poorly understood despite sleep disturbance contributing to morbidity in other scenarios. We aimed to investigate the prevalence and nature of sleep disturbance after discharge following hospital admission for COVID-19 and to assess whether this was associated with dyspnoea. Methods: CircCOVID was a prospective multicentre cohort substudy designed to investigate the effects of circadian disruption and sleep disturbance on recovery after COVID-19 in a cohort of participants aged 18 years or older, admitted to hospital for COVID-19 in the UK, and discharged between March, 2020, and October, 2021. Participants were recruited from the Post-hospitalisation COVID-19 study (PHOSP-COVID). Follow-up data were collected at two timepoints: an early time point 2–7 months after hospital discharge and a later time point 10–14 months after hospital discharge. Sleep quality was assessed subjectively using the Pittsburgh Sleep Quality Index questionnaire and a numerical rating scale. Sleep quality was also assessed with an accelerometer worn on the wrist (actigraphy) for 14 days. Participants were also clinically phenotyped, including assessment of symptoms (ie, anxiety [Generalised Anxiety Disorder 7-item scale questionnaire], muscle function [SARC-F questionnaire], dyspnoea [Dyspnoea-12 questionnaire] and measurement of lung function), at the early timepoint after discharge. Actigraphy results were also compared to a matched UK Biobank cohort (non-hospitalised individuals and recently hospitalised individuals). Multivariable linear regression was used to define associations of sleep disturbance with the primary outcome of breathlessness and the other clinical symptoms. PHOSP-COVID is registered on the ISRCTN Registry (ISRCTN10980107). Findings: 2320 of 2468 participants in the PHOSP-COVID study attended an early timepoint research visit a median of 5 months (IQR 4–6) following discharge from 83 hospitals in the UK. Data for sleep quality were assessed by subjective measures (the Pittsburgh Sleep Quality Index questionnaire and the numerical rating scale) for 638 participants at the early time point. Sleep quality was also assessed using device-based measures (actigraphy) a median of 7 months (IQR 5–8 months) after discharge from hospital for 729 participants. After discharge from hospital, the majority (396 [62%] of 638) of participants who had been admitted to hospital for COVID-19 reported poor sleep quality in response to the Pittsburgh Sleep Quality Index questionnaire. A comparable proportion (338 [53%] of 638) of participants felt their sleep quality had deteriorated following discharge after COVID-19 admission, as assessed by the numerical rating scale. Device-based measurements were compared to an age-matched, sex-matched, BMI-matched, and time from discharge-matched UK Biobank cohort who had recently been admitted to hospital. Compared to the recently hospitalised matched UK Biobank cohort, participants in our study slept on average 65 min (95% CI 59 to 71) longer, had a lower sleep regularity index (–19%; 95% CI –20 to –16), and a lower sleep efficiency (3·83 percentage points; 95% CI 3·40 to 4·26). Similar results were obtained when comparisons were made with the non-hospitalised UK Biobank cohort. Overall sleep quality (unadjusted effect estimate 3·94; 95% CI 2·78 to 5·10), deterioration in sleep quality following hospital admission (3·00; 1·82 to 4·28), and sleep regularity (4·38; 2·10 to 6·65) were associated with higher dyspnoea scores. Poor sleep quality, deterioration in sleep quality, and sleep regularity were also associated with impaired lung function, as assessed by forced vital capacity. Depending on the sleep metric, anxiety mediated 18–39% of the effect of sleep disturbance on dyspnoea, while muscle weakness mediated 27–41% of this effect. Interpretation: Sleep disturbance following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness. Due to the association with multiple symptoms, targeting sleep disturbance might be beneficial in treating the post-COVID-19 condition. Funding: UK Research and Innovation, National Institute for Health Research, and Engineering and Physical Sciences Research Council